Common Stock, Shares, Outstanding of KalVista Pharmaceuticals, Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
KalVista Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • KalVista Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 50,542,711, a 17% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

KalVista Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 50,542,711 +7,271,210 +17% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 50,339,823 +7,257,901 +17% 31 Jul 2025 10-Q 11 Sep 2025 2026 Q1
Q1 2025 49,762,048 +7,240,073 +17% 30 Apr 2025 10-Q 11 Sep 2025 2026 Q1
Q4 2024 49,433,611 +14,837,988 +43% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 43,271,501 +8,850,043 +26% 31 Oct 2024 10-Q 05 Dec 2024 2025 Q2
Q2 2024 43,081,922 +8,815,327 +26% 31 Jul 2024 10-Q 05 Sep 2024 2025 Q1
Q1 2024 42,521,975 +8,350,837 +24% 30 Apr 2024 10-K 10 Jul 2025 2025 FY
Q4 2023 34,595,623 +467,861 +1.4% 31 Jan 2024 10-Q 11 Mar 2024 2024 Q3
Q3 2023 34,421,458 +9,819,435 +40% 31 Oct 2023 10-Q 07 Dec 2023 2024 Q2
Q2 2023 34,266,595 +9,695,723 +39% 31 Jul 2023 10-Q 07 Sep 2023 2024 Q1
Q1 2023 34,171,138 +9,620,390 +39% 30 Apr 2023 10-K 11 Jul 2024 2024 FY
Q4 2022 34,127,762 +9,590,668 +39% 31 Jan 2023 10-Q 09 Mar 2023 2023 Q3
Q3 2022 24,602,023 +158,591 +0.65% 31 Oct 2022 10-Q 08 Dec 2022 2023 Q2
Q2 2022 24,570,872 +133,357 +0.55% 31 Jul 2022 10-Q 08 Sep 2022 2023 Q1
Q1 2022 24,550,748 +128,217 +0.52% 30 Apr 2022 10-K 10 Jul 2023 2023 FY
Q4 2021 24,537,094 +6,515,870 +36% 31 Jan 2022 10-Q 10 Mar 2022 2022 Q3
Q3 2021 24,443,432 +6,527,917 +36% 31 Oct 2021 10-Q 09 Dec 2021 2022 Q2
Q2 2021 24,437,515 +6,557,101 +37% 31 Jul 2021 10-Q 09 Sep 2021 2022 Q1
Q1 2021 24,422,531 +6,576,932 +37% 30 Apr 2021 10-K 07 Jul 2022 2022 FY
Q4 2020 18,021,224 +175,625 +0.98% 31 Jan 2021 10-Q 11 Mar 2021 2021 Q3
Q3 2020 17,915,515 +81,389 +0.46% 31 Oct 2020 10-Q 10 Dec 2020 2021 Q2
Q2 2020 17,880,414 +64,921 +0.36% 31 Jul 2020 10-Q 14 Sep 2020 2021 Q1
Q1 2020 17,845,599 +567,849 +3.3% 30 Apr 2020 10-K 13 Jul 2021 2021 FY
Q4 2019 17,845,599 +598,293 +3.5% 31 Jan 2020 10-Q 10 Mar 2020 2020 Q3
Q3 2019 17,834,126 +608,959 +3.5% 31 Oct 2019 10-Q 03 Dec 2019 2020 Q2
Q2 2019 17,815,493 +7,015,598 +65% 31 Jul 2019 10-Q 09 Sep 2019 2020 Q1
Q1 2019 17,277,750 +6,477,855 +60% 30 Apr 2019 10-K 01 Jul 2020 2020 FY
Q4 2018 17,247,306 +6,454,660 +60% 31 Jan 2019 10-Q 14 Mar 2019 2019 Q3
Q3 2018 17,225,167 +6,441,536 +60% 31 Oct 2018 10-Q 14 Dec 2018 2019 Q2
Q2 2018 10,799,895 +1,086,853 +11% 31 Jul 2018 10-Q 14 Sep 2018 2019 Q1
Q1 2018 10,799,895 +1,086,853 +11% 30 Apr 2018 10-K 16 Jul 2019 2019 FY
Q4 2017 10,792,646 +1,079,604 +11% 31 Jan 2018 10-Q 16 Mar 2018 2018 Q3
Q3 2017 10,783,631 -15,560,473 -59% 31 Oct 2017 10-Q 14 Dec 2017 2018 Q2
Q2 2017 9,713,042 -16,622,733 -63% 31 Jul 2017 10-Q 14 Sep 2017 2018 Q1
Q1 2017 9,713,042 -16,619,452 -63% 30 Apr 2017 10-K 30 Jul 2018 2018 FY
Q4 2016 9,713,042 -16,609,452 -63% 31 Jan 2017 10-Q 16 Mar 2017 2016 Q3
Q3 2016 26,344,104 +21,610 +0.08% 30 Sep 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 26,335,775 +13,281 +0.05% 30 Jun 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 26,332,494 +25,624,037 +3617% 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q4 2015 26,322,494 +25,631,182 +3708% 31 Dec 2015 10-Q 08 Nov 2016 2016 Q3
Q3 2015 26,322,494 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 26,322,494 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 708,457 31 Mar 2015 10-Q 21 May 2015 2015 Q1
Q4 2014 691,312 31 Dec 2014 10-K 30 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.